Shandong Pharmaceutical (600529.SH) released semi-annual results, with net profit of 371 million yuan to mother, a year-on-year decrease of 0.07%

Zhitongcaijing · 2d ago

According to Zhitong Finance App News, Shandong Pharmaceutical (600529.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved operating income of 2,280 million yuan, an increase of 1.34%; net profit to mother of 371 million yuan, a year-on-year decrease of 0.07%; deducted non-net profit of 354 million yuan, a year-on-year decrease of 0.16%; and basic earnings per share of 0.5589 yuan. The company plans to distribute cash of 3.00 yuan (tax included) for every 10 shares to all shareholders.